Gustavo A. Abraham

Dr. Gustavo A. Abraham

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
AAAna Agustina Aldana
Ana Agustina Aldana
Gustavo A. AbrahamGustavo A. Abraham
Gustavo A. Abraham
The development of biomimetic highly-porous scaffolds is essential for successful tissue engineering. Electrospun nanofibers are highly versatile platforms for a broad range of applications in different research areas. In the biomedical field, micro/nanoscale fibrous structures have gained great interest for wound dressings, drug delivery systems, soft and hard-tissue engineering scaffolds, enzyme immobilization, among other healthcare applications. In this mini-review, electrospun gelatin-based scaffolds for a variety of tissue engineering applications, such as bone, cartilage, skin, nerve, and ocular and vascular tissue engineering, are reviewed and discussed. Gelatin blends with natural or synthetic polymers exhibit physicochemical, biomechanical, and biocompatibility properties very attractive for scaffolding. Current advances and challenges on this research field are presented.


1 August 2011 in Progress in Polymer Science
Verified
Journal Article
Closed access
ASAlejandro Sosnik
Alejandro Sosnik
GGGustavo Gotelli
Gustavo Gotelli
Gustavo A. AbrahamGustavo A. Abraham
Gustavo A. Abraham

9 January 2007 in Journal of Polymer Science Part B: Polymer Physics
Verified
Journal Article
Closed access
PDF file
FBFabian Buffa
Fabian Buffa
Gustavo A. AbrahamGustavo A. Abraham
Gustavo A. Abraham
BGBrian P. Grady
Brian P. Grady
DRDaniel Resasco
Daniel Resasco

18 January 2019 in Nanomaterials
Verified
Journal Article
Open access
PDF file
AAAna Agustina Aldana
Ana Agustina Aldana
LMLaura Malatto
Laura Malatto
MRMuahammad Atiq Ur Rehman
Muahammad Atiq Ur Rehman
Aldo R. BoccacciniAldo R. Boccaccini
Aldo R. Boccaccini
Gustavo A. AbrahamGustavo A. Abraham
Gustavo A. Abraham
The design of biomimetic biomaterials for cell culture has become a great tool to study and understand cell behavior, tissue degradation, and lesion. Topographical and morphological features play an important role in modulating cell behavior. In this study, a dual methodology was evaluated to generate novel gelatin methacrylate (GelMA)-based scaffolds with nano and micro topographical and morphological features. First, electrospinning parameters and crosslinking processes were optimized to obtain electrospun nanofibrous scaffolds. GelMA mats were characterized by SEM, FTIR, DSC, TGA, contact angle, and water uptake. Various nanofibrous GelMA mats with defect-free fibers and stability in aqueous media were obtained. Then, micropatterned molds produced by photolithography were used as collectors in the electrospinning process. Thus, biocompatible GelMA nanofibrous scaffolds with micro-patterns that mimic extracellular matrix were obtained successfully by combining two micro/nanofabrication techniques, electrospinning, and micromolding. Taking into account the cell viability results, the methodology used in this study could be considered a valuable tool to develop patterned GelMA based nanofibrous scaffolds for cell culture and tissue engineering.

1 July 2016 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Open access
German A. IslanGerman A. Islan
German A. Islan
PTPablo Cortez Tornello
Pablo Cortez Tornello
Gustavo A. AbrahamGustavo A. Abraham
Gustavo A. Abraham
NDNelson Duran
Nelson Duran
Guillermo Raul CastroGuillermo Raul Castro
Guillermo Raul Castro
Levofloxacin (LV) is a hydrophilic broad-spectrum antibiotic commonly used in pulmonary treatment against recurrent infections of Pseudomonas aeruginosa, and particularly in cystic fibrosis (CF) disease. In order to study feasible carriers for LV, solid lipid nanoparticles (SLN) of myristyl myristate were prepared by the ultrasonication method in the presence of Pluronic(®)F68 under different experimental conditions and characterized by dynamic light scattering, optical, transmission and scanning electron microscopy for size and morphology. Alternatively, nanostructured lipid carriers (NLCs) were developed to improve LV encapsulation and storage. SLN showed 20.1±1.4% LV encapsulation efficiency, while the NLCs encapsulated 55.9±1.6% LV. NLC formulation exhibited a more controlled release profile than SLN formulation, but both showed a biphasic drug release pattern with burst release at the first 5h and prolonged release afterwards, demonstrated by in vitro tests. The hydrodynamic average diameter and zeta potential of NLC were 182.6±3.2nm and -10.2±0.2mV, respectively, and were stable for at least 3 months. Additionally, DNase type I was incorporated into the formulations as a "smart" component, since the enzyme could help to decrease the viscoelasticity found in the lungs of CF patients and improves the antibiotic diffusion. FTIR, XRD, DSC, TGA and nitrogen adsorption isotherms of the nanoparticles indicate the presence of the loads in a noncrystalline state. The developed formulation showed an active antimicrobial activity against P. aeruginosa and even against other opportunistic pathogens such as Staphylococcus aureus. The presence of LV-loaded NLCs reduced the formation of a bacterial biofilm, which highlighted the significance of the nanodevice as a new alternative for CF treatment.